Kuriakose Emil
SEC insider (Form 3/4/5 filer). CIK 0001892413. Chief Medical Officer at Terns Pharmaceuticals, Inc. (TERN). 12 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in FOSTER CITY, CA.
Companies Kuriakose Emil has filed insider reports for
- Terns Pharmaceuticals, Inc. (TERN): Officer, Chief Medical Officer
Kuriakose Emil
CIK: 0001892413
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Terns Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 5, 2026TERN
Terns Pharmaceuticals, Inc.
Tender OfferDirect24.6K shares at avg. $53.00$1.3M - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirect82K shares at avg. $53.00$4.3M - Apr 1, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect942 shares at avg. $52.75$50K - Jan 14, 2026TERN
Terns Pharmaceuticals, Inc.
AwardDirect56.3K shares- - Jan 2, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect200 shares at avg. $39.60$8K - Jan 2, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect955 shares at avg. $38.36$37K - Oct 1, 2025TERN
Terns Pharmaceuticals, Inc.
SaleDirect944 shares at avg. $7.85$7K - Jul 1, 2025TERN
Terns Pharmaceuticals, Inc.
SaleDirect853 shares at avg. $4.27$4K - Apr 1, 2025TERN
Terns Pharmaceuticals, Inc.
SaleDirect952 shares at avg. $2.49$2K - Jan 30, 2025TERN
Terns Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
485K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Tender Offer | 24,562 | $53.00 | $1,301,786 | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition | 81,953 | $53.00 | $4,343,509 | Direct |
| Apr 1, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 942 | $52.75 | $49,693 | Direct |
| Jan 14, 2026 | TERN Terns Pharmaceuticals, Inc. | Award | 56,250 | - | $0 | Direct |
| Jan 2, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 200 | $39.60 | $7,920 | Direct |
| Jan 2, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 955 | $38.36 | $36,632 | Direct |
| Oct 1, 2025 | TERN Terns Pharmaceuticals, Inc. | Sale | 944 | $7.85 | $7,407 | Direct |
| Jul 1, 2025 | TERN Terns Pharmaceuticals, Inc. | Sale | 853 | $4.27 | $3,640 | Direct |
| Apr 1, 2025 | TERN Terns Pharmaceuticals, Inc. | Sale | 952 | $2.49 | $2,366 | Direct |
| Jan 30, 2025 | TERN Terns Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 485,000 | - | - | Direct |
1-10 of 12 transactions